The influence of pre-operative risk on the number of circulating endothelial progenitor cells during cardiopulmonary bypass

References

• Patterson C. The Ponzo effect: endothelial progenitor cells appear on the horizon. Circulation 2003;107:2995–7.
   PubMed Web of Science ®Google Scholar
• Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002;21:232–44.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, . Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434–8.
   PubMed Web of Science ®Google Scholar
• Denizot Y, Karoutsos S, Nathan N. Differential alterations in plasma colony-stimulating factor concentrations after coronary artery bypass graft surgery with extracorporeal circulation. Cytokine 2001;13:314–6.
   PubMed Web of Science ®Google Scholar
• Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J, . Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003;42:2073–80.
   PubMed Web of Science ®Google Scholar
• Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, . Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001;88:167–74.
   PubMed Web of Science ®Google Scholar
• Denizot Y, Guglielmi L, Cornu E, Nathan N. Alterations in plasma angiogenic growth factor concentrations after coronary artery bypass graft surgery: relationships with post-operative complications. Cytokine 2003;24:7–12.
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, . Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:E1–7.
   PubMed Web of Science ®Google Scholar
• Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, . Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981–7.
   PubMed Web of Science ®Google Scholar
• Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, . Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593–600.
   PubMed Web of Science ®Google Scholar
• Ding DC, Shyu WC, Lin SZ, Li H. The role of endothelial progenitor cells in ischemic cerebral and heart diseases. Cell Transplant 2007;16:273–84.
   PubMed Web of Science ®Google Scholar
• Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, . Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999–1007.
   PubMed Web of Science ®Google Scholar
• Mieno S, Ramlawi B, Boodhwani M, Clements RT, Minamimura K, Maki T, . Role of stromal-derived factor-1alpha in the induction of circulating CD34+CXCR4+ progenitor cells after cardiac surgery. Circulation 2006;114:I186–92.
   Web of Science ®Google Scholar
• Fukuhara S, Tomita S, Nakatani T, Ohtsu Y, Ishida M, Yutani C, . G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes. Cell Transplant 2004;13:741–8.
   PubMed Web of Science ®Google Scholar
• Walter DH, Zeiher AM, Dimmeler S. Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells. Coron Artery Dis 2004;15:235–42.
   PubMed Web of Science ®Google Scholar
• Walter DH, Dimmeler S, Zeiher AM. Effects of statins on endothelium and endothelial progenitor cell recruitment. Sem Vasc Med 2004;4:385–93.
   PubMedGoogle Scholar
• Urbich C, Dimmeler S. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int 2005; 67:1672–6.
   PubMed Web of Science ®Google Scholar
• Spyridopoulos I, Haendeler J, Urbich C, Brummendorf TH, Oh H, Schneider MD, . Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 2004;110:3136–42.
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, Schmidt-Lucke C, Bojunga S, Rossig L, Heeschen C, Dimmeler S, . Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for ‘pleiotropic’ functions of statin therapy. Eur Heart J 2006;27:1182–90.
   PubMed Web of Science ®Google Scholar
• Wiesenack C, Liebold A, Philipp A, Ritzka M, Koppenberg J, Birnbaum DE, . Four years’ experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. Artif Organs 2004;28:1082–8.
   PubMed Web of Science ®Google Scholar
• Skrabal CA, Choi YH, Kaminski A, Steiner M, Kundt G, Steinhoff G, . Circulating endothelial cells demonstrate an attenuation of endothelial damage by minimizing the extracorporeal circulation. J Thorac Cardiovasc Surg 2006;132:291–6.
   PubMed Web of Science ®Google Scholar
• Lemieux C, Cloutier I, Tanguay JF. Menstrual cycle influences endothelial progenitor cell regulation: a link to gender differences in vascular protection? Int J Cardiol 2009 Aug 14;136(2):200–10. Epub 2008 Jul 21
   PubMed Web of Science ®Google Scholar
• Wright DE, Bowman EP, Wagers AJ, Butcher EC, Weissman IL. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med 2002;195:1145–54.
   PubMed Web of Science ®Google Scholar
• Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004;95:343–53.
   PubMed Web of Science ®Google Scholar
• Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, . Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001;103:2776–9.
   PubMed Web of Science ®Google Scholar
• Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, Gravereaux E, . Vascular endothelial growth factor(165) gene transfer augments circulating endo-thelial progenitor cells in human subjects. Circ Res 2000;86:1198–202.
   PubMed Web of Science ®Google Scholar
• Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, . Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003;102:1340–6.
   PubMed Web of Science ®Google Scholar
• McClung JA, Naseer N, Saleem M, Rossi GP, Weiss MB, Abraham NG, . Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia 2005;48:345–50.
   PubMed Web of Science ®Google Scholar
• Roberts N, Xiao Q, Weir G, Xu Q, Jahangiri M. Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg 2007;83:598–605.
   PubMed Web of Science ®Google Scholar
• Duarte RF, Frank DA. SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways. Blood 2000;96:3422–30.
   PubMed Web of Science ®Google Scholar
• Powell TM, Paul JD, Hill JM, Thompson M, Benjamin M, Rodrigo M, . Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2005;25:296–301.
   PubMed Web of Science ®Google Scholar
• Hill JM, Syed MA, Arai AE, Powell TM, Paul JD, Zalos G, . Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 2005;46:1643–8.
   PubMed Web of Science ®Google Scholar
• Pompilio G, Cannata A, Peccatori F, Bertolini F, Nascimbene A, Capogrossi MC, . Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection. Ann Thorac Surg 2004;78:1808–12.
   PubMed Web of Science ®Google Scholar
• Stamm C, Liebold A, Steinhoff G, Strunk D. Stem cell therapy for ischemic heart disease: beginning or end of the road? Cell Transplant 2006;15(Suppl 1):S47–56.
   Google Scholar
• Stamm C, Kleine HD, Choi YH, Dunkelmann S, Lauffs JA, Lorenzen B, . Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007;133:717–25.
   PubMed Web of Science ®Google Scholar
• Nasseri BA, Kukucka M, Dandel M, Knosalla C, Potapov E, Lehmkuhl HB, . Intramyocardial delivery of bone marrow mononuclear cells and mechanical assist device implantation in patients with end-stage cardiomyopathy. Cell Transplant 2007;16:941–9.
   PubMed Web of Science ®Google Scholar